VP

Vijaya Pavan Kumar Gudivada

Active Director Managing Director DIN 11171705
DIN 11171705 First appointment Jun 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Vijaya Pavan Kumar Gudivada

Data last updated:

Vijaya Pavan Kumar Gudivada is a Managing Director at Medorix Pharma Private Limited (since 2025). The company operates in Pharma.

DIN 11171705
Primary Designation Managing Director
Industry Pharma
First Appointment 27 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medorix Pharma Private Limited U47721MH2025PTC451265
Managing Director27 Jun 20252025Active

Board colleagues of Vijaya Pavan Kumar Gudivada

NameDINCompanyDesignation
Sravanthi Gudivada11171704Medorix Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medorix Pharma Private Limited
Premium access

Shareholding and investment profile for Vijaya Pavan Kumar Gudivada

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijaya Pavan Kumar Gudivada

Vijaya Pavan Kumar Gudivada currently holds 1 directorship: Medorix Pharma Private Limited (Managing Director, since 27 Jun 2025).

Vijaya Pavan Kumar Gudivada was first appointed on 27 Jun 2025 as Managing Director at Medorix Pharma Private Limited.

The current boards of Vijaya Pavan Kumar Gudivada's companies include Sravanthi Gudivada (Medorix Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available